Bank Of America Corp Bluebird Bio, Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 1,411,743 shares of BLUE stock, worth $423,522. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,411,743

Previous 1,280,455 10.25%

Holding current value

$423,522

Previous $1.25 Million 41.47%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.47 - $1.35 $61,705 - $177,238	131,288 Added 10.25%	1,411,743 $734,000
Q2 2024 Aug 14, 2024	SELL	$0.85 - $1.26 $12,510 - $18,544	-14,718 Reduced 1.14%	1,280,455 $1.25 Million
Q1 2024 May 15, 2024	SELL	$0.91 - $1.75 $299,057 - $575,111	-328,635 Reduced 20.24%	1,295,173 $1.66 Million
Q4 2023 Feb 14, 2024	SELL	$1.32 - $4.83 $410,244 - $1.5 Million	-310,791 Reduced 16.06%	1,623,808 $2.24 Million
Q2 2023 Aug 14, 2023	SELL	$2.79 - $5.03 $85,580 - $154,290	-30,674 Reduced 1.56%	1,934,599 $6.36 Million
Q1 2023 May 12, 2023	BUY	$3.14 - $8.22 $3.97 Million - $10.4 Million	1,265,034 Added 180.66%	1,965,273 $6.25 Million
Q4 2022 Feb 10, 2023	BUY	$5.77 - $8.49 $615,889 - $906,222	106,740 Added 17.98%	700,239 $4.85 Million
Q3 2022 Nov 14, 2022	BUY	$3.75 - $7.39 $1.97 Million - $3.88 Million	525,005 Added 766.5%	593,499 $3.76 Million
Q2 2022 Aug 12, 2022	SELL	$2.94 - $5.23 $1.73 Million - $3.08 Million	-588,535 Reduced 89.58%	68,494 $283,000
Q1 2022 May 16, 2022	SELL	$4.07 - $10.6 $154,253 - $401,740	-37,900 Reduced 5.45%	657,029 $3.19 Million
Q4 2021 Feb 08, 2022	BUY	$8.96 - $16.31 $5.21 Million - $9.49 Million	581,642 Added 513.42%	694,929 $6.94 Million
Q3 2021 Nov 15, 2021	SELL	$11.24 - $21.0 $784,552 - $1.47 Million	-69,800 Reduced 38.12%	113,287 $2.17 Million
Q2 2021 Sep 13, 2021	BUY	$18.04 - $22.09 $3.3 Million - $4.04 Million	183,087 New	183,087 $5.86 Million

Others Institutions Holding BLUE

# of Institutions

151

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $23.1M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Bluebird Bio, Inc. Transaction History